risperidone has been researched along with blonanserin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahk, WM; Cho, HS; Jeon, YW; Jon, DI; Jung, HY; Kim, CH; Kim, HC; Kim, SH; Kim, YH; Kim, YK; Kwon, JS; Lee, SH; Lee, SY; Yang, J; Yi, JS; Yoon, BH | 1 |
| Akama, F; Andoh, H; Kato, K; Matsumoto, H; Sakaguchi, T; Sato, R | 1 |
| Hamaguchi, T; Motomura, E; Nakagawa, M; Ohoyama, K; Okada, M; Shiroyama, T; Tanii, H; Yamamura, S | 1 |
| Haga, T; Hashizume, T; Inoue, T; Katsumata, T; Ogawa, Y; Osada, K; Sogame, Y; Tagawa, M; Taguchi, A; Watanabe, T; Yabuki, M; Yamaguchi, N | 1 |
| Miki, T; Mizuki, Y; Takaki, M | 1 |
| Fukui, K; Fukushima, T; Hakariya, H; Ichiba, H; Iwasa, S; Shishikura, M; Yorita, K; Yoshio, T | 1 |
| Mizuki, Y; Takaki, M | 1 |
| Baba, S; Enomoto, T; Ikeda, K; Murai, T; Nakako, T; Ono, M; Shimizu, I | 1 |
| Gu, N; Li, H; Li, J; Li, K; Li, L; Liu, C; Luo, X; Qi, S; Shi, J; Wang, C; Wang, L; Wang, Q; Yang, F; Yao, C; Zhang, H | 1 |
| Harvey, PD; Miura, S; Nakamura, H | 1 |
| Lei, L; Li, H; Li, Y; Shen, Y; Yu, W; Yu, Y | 1 |
| Deng, SW; Hong, B; Jiang, WL; Li, BH; Sun, DW; Xu, Q; Yang, HB | 1 |
1 review(s) available for risperidone and blonanserin
| Article | Year |
|---|---|
Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antipsychotic Agents; Humans; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2023 |
4 trial(s) available for risperidone and blonanserin
| Article | Year |
|---|---|
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Weight Gain; Young Adult | 2010 |
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; China; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Piperidines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain; Young Adult | 2015 |
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Piperidines; Risperidone; Schizophrenia | 2020 |
Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Statistical; Piperazines; Piperidines; Prolactin; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2020 |
7 other study(ies) available for risperidone and blonanserin
| Article | Year |
|---|---|
Case of delirium complicated with pneumonia that improved with blonanserin administration.
Topics: Aged; Antipsychotic Agents; Delirium; Humans; Male; Piperazines; Piperidines; Pneumonia; Psychiatric Status Rating Scales; Psychomotor Agitation; Risperidone | 2010 |
Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Male; Microdialysis; Norepinephrine; Piperazines; Piperidines; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Telemetry | 2011 |
Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Brain; Cell Line, Transformed; Humans; Isoxazoles; LLC-PK1 Cells; Mice; Mice, Inbred Strains; Mice, Knockout; Paliperidone Palmitate; Piperazines; Piperidines; Pyrimidines; Risperidone; Swine | 2012 |
Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dystonia; Female; Humans; Olanzapine; Piperazines; Piperidines; Risperidone; Schizophrenia; Young Adult | 2014 |
Evaluation of human D-amino acid oxidase inhibition by anti-psychotic drugs in vitro.
Topics: Antipsychotic Agents; D-Amino-Acid Oxidase; Enzyme Activation; Humans; Piperazines; Piperidines; Risperidone | 2014 |
Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Piperazines; Piperidines; Risperidone; Schizophrenia | 2015 |
The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.
Topics: Animals; Antipsychotic Agents; Callithrix; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Executive Function; Haloperidol; Isoindoles; Male; Piperazines; Piperidines; Psychological Tests; Psychotropic Drugs; Pyrimidines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Risperidone; Serotonin 5-HT1 Receptor Agonists | 2015 |